Since PRMT3 inhibition activated cGAS/STING signaling through promoting mtDNA release, we decided to examine whether cGAS/STING hyperactivation directly contributes to the delayed tumor progression and increased T cell infiltration observed in Prmt3-KO or PRMT3 inhibitor-treated tumors. Here, CGAS is linked to neoplasm.